119 related articles for article (PubMed ID: 34704344)
21. [Campylobacter jejuni cellulitis].
Magand F; Lucht F
Ann Dermatol Venereol; 2009 Dec; 136(12):904. PubMed ID: 20004318
[No Abstract] [Full Text] [Related]
22. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Lehtopolku M; Kotilainen P; Haanperä-Heikkinen M; Nakari UM; Hänninen ML; Huovinen P; Siitonen A; Eerola E; Jalava J; Hakanen AJ
Antimicrob Agents Chemother; 2011 Dec; 55(12):5939-41. PubMed ID: 21911571
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Resistance of Human
Otto SJG; Levett PN; Reid-Smith RJ; Pearl DL; Daku D; Nagle E; Horsman GB; McEwen SA
Foodborne Pathog Dis; 2020 Mar; 17(3):178-186. PubMed ID: 31661323
[TBL] [Abstract][Full Text] [Related]
24. A Highly Macrolide-Resistant Campylobacter jejuni Strain with Rare A2074T Mutations in 23S rRNA Genes.
Ohno H; Wachino J; Saito R; Jin W; Yamada K; Kimura K; Arakawa Y
Antimicrob Agents Chemother; 2016 Apr; 60(4):2580-1. PubMed ID: 26810658
[No Abstract] [Full Text] [Related]
25. Antibiotic resistance in Campylobacter: emergence, transmission and persistence.
Luangtongkum T; Jeon B; Han J; Plummer P; Logue CM; Zhang Q
Future Microbiol; 2009 Mar; 4(2):189-200. PubMed ID: 19257846
[TBL] [Abstract][Full Text] [Related]
26. Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia.
Hagiya H; Kimura K; Nishi I; Yoshida H; Yamamoto N; Akeda Y; Tomono K
Intern Med; 2018 Jul; 57(14):2077-2080. PubMed ID: 29491300
[TBL] [Abstract][Full Text] [Related]
27. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Cagliero C; Mouline C; Cloeckaert A; Payot S
Antimicrob Agents Chemother; 2006 Nov; 50(11):3893-6. PubMed ID: 16940070
[TBL] [Abstract][Full Text] [Related]
28. A cross-sectional study of the prevalence factors associated with fluoroquinolone resistant Campylobacter jejuni in broiler flocks in Canada.
Caffrey N; Agunos A; Gow S; Liljebjelke K; Waldner CL; Mainali C; Checkley SL
Prev Vet Med; 2021 Jan; 186():105164. PubMed ID: 33285388
[TBL] [Abstract][Full Text] [Related]
29. Recurrent Cellulitis Caused by Helicobacter cinaedi in a Patient with X-linked Agammaglobulinaemia.
Sugimoto M; Takeichi T; Muramatsu H; Kojima D; Osada Y; Kono M; Kojima S; Akiyama M
Acta Derm Venereol; 2017 Feb; 97(2):277-278. PubMed ID: 27377098
[No Abstract] [Full Text] [Related]
30. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni.
Caldwell DB; Wang Y; Lin J
Antimicrob Agents Chemother; 2008 Nov; 52(11):3947-54. PubMed ID: 18779354
[TBL] [Abstract][Full Text] [Related]
31. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
Gibreel A; Wetsch NM; Taylor DE
Antimicrob Agents Chemother; 2007 Sep; 51(9):3212-6. PubMed ID: 17606685
[TBL] [Abstract][Full Text] [Related]
32. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains.
Pérez-Boto D; López-Portolés JA; Simón C; Valdezate S; Echeita MA
J Antimicrob Chemother; 2010 Oct; 65(10):2083-8. PubMed ID: 20647243
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Lehtopolku M; Nakari UM; Kotilainen P; Huovinen P; Siitonen A; Hakanen AJ
Antimicrob Agents Chemother; 2010 Mar; 54(3):1232-6. PubMed ID: 20038624
[TBL] [Abstract][Full Text] [Related]
34. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni.
Hao H; Dai M; Wang Y; Peng D; Liu Z; Yuan Z
Microb Drug Resist; 2009 Dec; 15(4):239-44. PubMed ID: 19857128
[TBL] [Abstract][Full Text] [Related]
35. Emergence of multidrug-resistant Campylobacter species isolates with a horizontally acquired rRNA methylase.
Wang Y; Zhang M; Deng F; Shen Z; Wu C; Zhang J; Zhang Q; Shen J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5405-12. PubMed ID: 24982085
[TBL] [Abstract][Full Text] [Related]
36. Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.
Hao H; Yuan Z; Shen Z; Han J; Sahin O; Liu P; Zhang Q
Antimicrob Agents Chemother; 2013 Mar; 57(3):1369-78. PubMed ID: 23274667
[TBL] [Abstract][Full Text] [Related]
37. Report of ribosomal RNA methylase gene erm(B) in multidrug-resistant Campylobacter coli.
Qin S; Wang Y; Zhang Q; Zhang M; Deng F; Shen Z; Wu C; Wang S; Zhang J; Shen J
J Antimicrob Chemother; 2014 Apr; 69(4):964-8. PubMed ID: 24335515
[TBL] [Abstract][Full Text] [Related]
38. Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia.
van den Bruele T; Mourad-Baars PE; Claas EC; van der Plas RN; Kuijper EJ; Bredius RG
Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1315-9. PubMed ID: 20556465
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization and genotypic antimicrobial resistance analysis of Campylobacter jejuni and Campylobacter coli isolated from broiler flocks in northern Italy.
Giacomelli M; Andrighetto C; Rossi F; Lombardi A; Rizzotti L; Martini M; Piccirillo A
Avian Pathol; 2012 Dec; 41(6):579-88. PubMed ID: 23237371
[TBL] [Abstract][Full Text] [Related]
40. Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.
Gomez-Garces JL; Cogollos R; Alos JL
Antimicrob Agents Chemother; 1995 Feb; 39(2):542-44. PubMed ID: 7726529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
